BLOG / 🇮🇳 India / distress insolvency · · daily

India NCLT Insolvency Resolution Filings — October 15, 2026

India Corporate Insolvency & NCLT

By Gunpowder Editorial ·

6 high priority 1 medium priority 7 total filings analysed

Executive Summary

Seven filings for the India Corporate Insolvency & NCLT stream cover six companies in active CIRP or post-approval implementation, plus one Monitoring Committee disclosure tied to a company whose name is inconsistent across the filing.

The filings are overwhelmingly procedural: CoC meeting notices (Quadrant Televentures, Astron Paper, Future Enterprises), a post-facto CoC meeting intimation (Simbhaoli Sugars), a Monitoring Committee meeting record (Devika/Dharti Proteins), and two substantive NCLT orders (Rajeswari Infrastructure, VXL Instruments). None of the filings contain period-over-period financial figures, forward guidance, insider trading, pledges, dividends, or buyback data, so the enriched period-comparison and capital-allocation fields carry no quantitative signal this cycle; the intelligence value lies in timelines, legal risk and resolution-plan execution. The most material developments are the Rajeswari NCLT order (90-day implementation extension but rejection of the 119/98-day exclusion request, plus a forced non-core asset sale) and the VXL Instruments implementation deadlock caused by paragraph 43(m) of the approval order, which renders merger-dependent clauses inoperable. Astron Paper carries the most negative sentiment and a 6th CoC meeting on October 19, 2026, while Future Enterprises' 45th CoC meeting on October 17 signals a long-running process. The common theme is that resolution timelines are slipping and implementation is being litigated or re-papered rather than executed on schedule.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Insolvency

Tracking the trend? Catch up on the prior India NCLT Insolvency Resolution Filings digest from October 14, 2026.

Investment Signals (9)

  • NCLT approved a resolution plan on 9 September 2026 with NG Organics Private Limited and Mr. Nitinbhai Govindbhai Patel as SRAs; SRA has applied under Section 60(5) of IBC to modify clauses while stating CoC-approved financial terms are unchanged and fully funded

  • NCLT Chennai granted a 90-day extension to implement the approved resolution plan, giving the SRA additional runway despite the rejected exclusion request

  • Buyer already identified for two non-core assets with no valuation dispute, and the sale proceeds path to release of Intec Capital and Religare Finvest charges is clear, which supports deleveraging

  • Deemed Resolution Professional Atul Sheth appointed by NCLT Ahmedabad effective May 11, 2026, with the 6th CoC meeting on October 19, 2026 at 3:00 PM, indicating active committee-level decision-making

  • 4th CoC meeting, adjourned and resumed on 30 September, concluded on 13 October 2026, confirming the committee is progressing through its agenda under IRP Anurag Goel

  • 17th CoC meeting scheduled for October 17, 2026, a high meeting count after a September 2, 2025 admission, which points to a protracted process with uncertain plan timing

  • 45th CoC meeting scheduled for October 17, 2026 at 4:00 PM, an unusually high count that signals a prolonged CIRP with repeated deferrals

  • Registered office relocated to Sola, Ahmedabad, and the filing is categorized negative, consistent with a company in restructuring transition with no quantified recovery

  • Dharti Proteins (Devika Proteins) (BEARISH)
    ▲

    4th Monitoring Committee meeting held October 15, 2026 for only 37 minutes with no disclosed decisions, suggesting limited near-term resolution progress

Risk Flags (8)

  • Paragraph 43(m) of the NCLT Approval Order makes the original merger-dependent clauses inoperable; implementation is stalled pending Section 60(5) modification and NCLT directions, with management remaining with the Monitoring Committee

  • NCLT declined the request to exclude 119 days (or 98 days) from the implementation period, so the SRA faces tighter milestones even after the 90-day extension

  • SRA directed to sell two non-core assets, with proceeds routed to Intec Capital Ltd. and Religare Finvest Ltd. before charges are released, constraining the SRA's control over disposal sequencing

  • 6th CoC meeting on October 19, 2026 with a deemed RP appointment and a negative sentiment classification, no disclosed plan timeline or recovery estimate

  • 17th CoC meeting roughly 13 months after the September 2, 2025 admission, a meeting cadence that implies a long and possibly litigated path to resolution

  • 45th CoC meeting indicates an extended process with a large cumulative number of committee sessions and no disclosed resolution milestone

  • Dharti Proteins (Devika Proteins)/Identity and Disclosure Risk [MEDIUM RISK]
    ▼

    The filing header names Devika Proteins Ltd while the signature block and body name Dharti Proteins Limited (scrip DHARTI, company code 531171), a discrepancy that could indicate disclosure errors or a corporate name change needing verification

  • The 4th CoC meeting was held September 30 but disclosed only after conclusion on October 13, which raises questions about timeliness of Regulation 30 intimations

Opportunities (7)

Sector Themes (5)

  • Implementation Slippage Under IBC Approved Plans (HIGH IMPLICATION)
    ◆

    Two of seven filings (VXL Instruments, Rajeswari Infrastructure) show approved resolution plans running into implementation problems, one from a drafting defect in the approval order and one from timeline and asset-sale constraints, suggesting post-approval execution risk is a recurring pattern in the stream

  • Protracted CIRP Cadence (MEDIUM IMPLICATION)
    ◆

    Quadrant Televentures (17th CoC), Future Enterprises (45th CoC), and Simbhaoli Sugars (4th CoC, CIRP since July 2024) indicate that high CoC meeting counts and long CIRP durations are common, which implies extended holding periods and low visibility on recoveries

  • Clustering of CoC Meetings in Mid-October 2026 (MEDIUM IMPLICATION)
    ◆

    Quadrant (Oct 17), Future Enterprises (Oct 17), Astron Paper (Oct 19) and Simbhaoli (concluded Oct 13) all have committee activity in a tight window, so investors tracking the stream should expect a dense cluster of exchange disclosures over the next week

  • Procedural Filing Dominance with Disclosure Quality Issues (LOW IMPLICATION)
    ◆

    Most filings are notice-only with no financial data, and the Dharti/Devika name mismatch and the post-facto Simbhaoli intimation show that exchange disclosures in this stream are not consistently timely or accurate, raising the bar for independent verification

  • Regulatory Reliance on Section 60(5) and Section 31 Modifications (MEDIUM IMPLICATION)
    ◆

    The VXL SRA's use of Section 60(5) to modify clauses post-approval shows that NCLT remains the forum for resolving drafting and implementation gaps, and that approval orders are not always executable as written

Watch List (8)

  • Watch for NCLT ruling on the SRA's Section 60(5) application to modify merger-dependent clauses under paragraph 43(m); the implementation timeline depends on this decision and no date has been disclosed

  • Monitor the 90-day implementation window opened by the October 12, 2026 NCLT order, the sale of the two non-core assets, and release of Intec Capital and Religare Finvest charges

  • 6th CoC meeting on Monday, October 19, 2026 at 3:00 PM; watch for resolution strategy, plan invitation, or any further NCLT orders on the Deemed RP's mandate

  • 45th CoC meeting on Saturday, October 17, 2026 at 4:00 PM; monitor the minutes or outcome disclosure and any change in the resolution plan timeline

  • 17th CoC meeting on Saturday, October 17, 2026; watch for any movement toward a resolution plan given the protracted CIRP since September 2, 2025

  • Post-conclusion CoC decisions from the 4th meeting concluded October 13, 2026, and any subsequent exchange disclosure on resolution plan progress under IRP Anurag Goel

  • Dharti Proteins (formerly listed as Devika Proteins)
    👁

    Verify the company name and scrip mapping (DHARTI / company code 531171) and track the next Monitoring Committee meeting and any Erstwhile RP updates

  • NCLT Chennai and Ahmedabad Benches
    👁

    Monitor orders and any appellate filings on Rajeswari Infrastructure and Astron Paper, given that the Rajeswari exclusion request was rejected and appeals or applications may follow

Filing Analyses (7)
Quadrant Televentures Limited Insolvency neutral materiality 5/10

15-10-2026

Quadrant Televentures Limited, which has been under Corporate Insolvency Resolution Process (CIRP) since the NCLT admitted it on September 2, 2025, has intimated BSE that the 17th meeting of its Committee of Creditors is scheduled for Saturday, October 17, 2026. The filing is a procedural regulatory disclosure under Regulation 30 of the SEBI LODR Regulations and contains no financial results, amounts, or resolution plan details.

  • · CIRP was initiated under Section 7 of the Insolvency and Bankruptcy Code, 2016, following NCLT admission on September 2, 2025
  • · The filing is made under Regulation 30 read with Clause 16(g) of Para A of Part A of Schedule III of SEBI LODR Regulations, 2015
  • · BSE scrip code is 511116
Simbhaoli Sugars Limited Insolvency neutral materiality 4/10

15-10-2026

Simbhaoli Sugars Limited has filed a post-facto intimation with BSE and NSE regarding the 4th Meeting of its Committee of Creditors (CoC), held on 30th September 2026 and concluded on 13th October 2026 under Section 24 of the Insolvency and Bankruptcy Code, 2016. The company remains under the Corporate Insolvency Resolution Process (CIRP), which commenced on 11th July 2024, with Mr. Anurag Goel serving as Interim Resolution Professional managing the company's assets and affairs. The filing is informational in nature and discloses no financial figures, outcomes of CoC decisions, or resolution plan details.

  • · CIRP commenced w.e.f. 11th July 2024 via adjudicating authority order dated 11th July 2024
  • · Board of Directors powers stand suspended; IRP manages assets, management and functions under IBC
  • · The 4th CoC meeting was adjourned, resumed on 30th September 2026, and concluded on 13th October 2026
Astron Paper & Board Mill Limited Insolvency negative materiality 7/10

15-10-2026

Astron Paper and Board Mill Limited is under the Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016, effective May 11, 2026, with Mr. Atul Sheth appointed as Deemed Resolution Professional by the NCLT Ahmedabad Bench. The company has disclosed that the 6th meeting of its Committee of Creditors is scheduled for Monday, October 19, 2026 at 3:00 PM. The filing contains no quantitative financial figures.

  • · Company registered office moved from D-702, Ganesh Meriden, Ahmedabad to 407, Satyamev Eminence, Science City, Sola, Ahmedabad-380060
  • · NCLT Ahmedabad Bench order dated May 11, 2026 was published on the NCLT website on May 15, 2026
  • · Filing made under Regulation 30 of SEBI LODR and sub-clause 16(9) of Clause A of Part A of Schedule III
Devika Proteins Ltd Market Update neutral materiality 4/10

15-10-2026

Dharti Proteins Limited (BSE scrip DHARTI, ISIN INE248C01021) has disclosed under Regulation 30 of the SEBI LODR Regulations that the 04th Meeting of its Monitoring Committee was held on October 15, 2026, via video conference, running from 5:00 P.M. to 5:37 P.M. The filing is signed by CS & IP Amrish Gandhi, identified as the Erstwhile Resolution Professional, which indicates the company is or was under the insolvency resolution process. No financial figures, operational results, or specific decisions are disclosed in the filing.

  • · Company name discrepancy: the filing header references Devika Proteins Ltd while the signature block and letter body reference Dharti Proteins Limited; scrip code is DHARTI, company code 531171
  • · Signatory is the Erstwhile Resolution Professional, with IBBI registration IBBI/IPA-002/IP-N00670/2018-2019/12036 and AFA valid up to December 31, 2026
  • · Filing was signed on October 15, 2026 at 18:17:47 IST, the same day as the meeting
Rajeswari Infrastructure Limited Insolvency mixed materiality 7/10

15-10-2026

Rajeswari Infrastructure Limited disclosed that the Hon'ble NCLT Chennai Bench, in its order dated 12.10.2026 (under the earlier 13.01.2026 plan approval order), granted a 90-day extension for implementation of the approved Resolution Plan. The Tribunal declined the Company's request to exclude 119 days (or an alternative 98 days) from the implementation period, and directed the Resolution Professional/SRA to sell two non-core assets, with proceeds going to Intec Capital Ltd. and Religare Finvest Ltd., which must then release their charges. The sentiment is mixed: the 90-day extension and asset-sale direction advance resolution, while the rejection of the exclusion request leaves the Company under tighter timelines.

  • · NCLT declined the Applicant's request to exclude 119 days (or alternatively 98 days) from the implementation period under the approved Resolution Plan
  • · SRA directed to sell two non-core assets; buyer already identified and no valuation dispute exists
  • · Intec Capital Ltd. and Religare Finvest Ltd. directed to release charges/liens on the non-core assets upon deposit of sale proceeds
  • · Property Tax Department attachment on assets referred to SRA for resolution; no claim was filed by the department during CIRP
  • · Company's Managing Director signed the disclosure; filing made to BSE under SEBI LODR Regulations
Future Enterprises Limited Insolvency neutral materiality 4/10

15-10-2026

Future Enterprises Limited, currently under the Corporate Insolvency Resolution Process (CIRP), has informed BSE and NSE that the 45th meeting of its Committee of Creditors (CoC) will be held on Saturday, 17 October 2026 at 4:00 PM. The intimation was made under Regulation 30 of SEBI LODR and sub-clause 16(g) of Part A of Schedule III, and was submitted by Resolution Professional Avil Menezes. The filing contains no monetary amounts, financial results, or performance metrics.

  • · Regulatory basis: Regulation 30 of SEBI LODR and sub-clause 16(g) of Clause A of Part A of Schedule III
  • · Resolution Professional registration: IBBI/IPA-001/IP-P00017/2016-17/10041; authorization valid till 30 June 2027
  • · Exchange scrip codes: BSE 523574/570002; NSE symbols FEL/FELDVR
VXL Instruments Ltd. Insolvency mixed materiality 7/10

15-10-2026

VXL Instruments Ltd., under Corporate Insolvency Resolution Process since the NCLT Mumbai Bench order of 26 November 2024, reports that the NCLT approved a Resolution Plan on 9 September 2026 under Section 31 of the IBC, with NG Organics Private Limited and Mr. Nitinbhai Govindbhai Patel as Successful Resolution Applicants. Implementation has stalled because paragraph 43(m) of the Approval Order requires the merger of NG Organics with VXL to follow the Companies Act, 2013 procedure, which makes the original merger-dependent clauses inoperable; the SRA has applied under Section 60(5) of IBC for approval of modified clauses, which it says leave the CoC-approved financial and commercial terms unchanged and that it has fully funded. Management remains with the Monitoring Committee pending NCLT directions.

  • · NCLT Approval Order dated 9 September 2026 in IA (IBC) (Plan) No. 69 of 2025 in CP (IB) No. 570 of 2024
  • · Earlier exchange announcements on 10 and 11 September 2026 regarding the approval
  • · Paragraph 43(m) of the Approval Order requires the merger to be subject to Companies Act, 2013 procedure, rendering merger-dependent clauses inoperable in original form
  • · Share issuance to NG Organics shareholders under the original merger structure is now uncertain pending modified clauses
  • · The modified clauses reportedly do not alter the financial or commercial terms approved by the Committee of Creditors
  • · The SRA states it has funded the entire consideration under the Resolution Plan
  • · Company will keep the Exchange informed upon receipt of NCLT directions

Get daily alerts with 9 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 7 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: India NCLT Insolvency Resolution Filings

🇮🇳 More from India

View all →